Cagrilintide 10mg

$74.99

Cagrilintide 10mg (99% purity). Lyophilized in a sterile, sealed vial for controlled laboratory research. Diluent not included. For research use only — not for human consumption.

CAGRILINTIDE 10MG

Research-grade amylin-pathway compound  prepared for consistency and clear documentation in professional lab workflows.

Specifications

 

 

  • Compound: Cagrilintide

  • Class/Target: Long-acting amylin receptor agonist (calcitonin receptor + RAMP complexes)

  • Form/Appearance: Lyophilized powder, white to off-white

  • Amount: 10mg per vial

  • Purity: ≥99%

  • Storage (lyophilized): Cool, dry, away from light

  • Storage (after reconstitution): Refrigerate and use promptly per internal SOP

 

 

What’s Included

 

 

  • 1 × Cagrilintide 10mg vial (no diluent)

 

 

Handling

 

Use an appropriate sterile diluent and aseptic technique. Follow your lab SOPs for reconstitution, aliquoting, labeling, and disposal.

 

Research Snapshot

 

 

  • Amylin receptor agonism has been shown to reduce energy intake and body weight in preclinical models and randomized human studies, with effects attributed to enhanced satiety and delayed gastric emptying.

  • Cagrilintide is an acylated, long-acting analog designed for extended exposure in once-weekly study protocols via albumin binding.

  • Combination protocols pairing an amylin-pathway agonist with a GLP-1 receptor agonist have reported additive weight-loss effects versus either agent alone in clinical trials.

  • The most common study-reported adverse events are gastrointestinal, including nausea and vomiting, typically mitigated by dose titration.

  • Cagrilintide remains investigational and is not approved for medical use.

 

 

Compliance

 

For research use only. Not for human consumption.


Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.